ASH Names New Blood Editor in Chief
Five-year term of Dr. Andrew Roberts to begin in January 2025 (WASHINGTON, Oct. 31, 2024) — The ÎÚÑ»´«Ã½ (ASH) has selected Andrew Roberts, MBBS, PhD, clinical hematologist at the Royal Melbourne Hospital and Peter MacCallum Ca...
Read moreNew Leadership Elected to the ÎÚÑ»´«Ã½
(WASHINGTON, October 28, 2024) – The ÎÚÑ»´«Ã½ (ASH), the world’s largest professional society focused on advancing the field of blood disorders, announced the election of four new members to its Executive Committee f...
Read moreASH Announces Editors in Chief of Two New Blood Journals
Drs. Willem Fibbe and Patrick Gallagher selected to head new specialty hematology publications (WASHINGTON, Oct. 9, 2024) — The ÎÚÑ»´«Ã½ (ASH) has selected Willem Fibbe, MD, and Patrick Gallagher, MD, to serve as the inau...
Read moreFood Deserts, Limited Access to Transportation Linked to More Complications Among Preschool Children with SCD
Social factors significantly affected patient health despite wrap-around care (WASHINGTON – October 7, 2024) - A new study finds that preschool-aged children with sickle cell disease (SCD) who live in food deserts and have limited access to transpo...
Read moreCilta-cel Found Highly Effective in First Real-World Study
Study shows strong alignment between real-world outcomes and those seen in clinical trials among a broad population of patients with relapsed or refractory multiple myeloma (WASHINGTON – October 4, 2024) In the first study to report real-world outco...
Read moreCAR-T Safe and Effective on an Outpatient Basis
Study of liso-cel in patients with relapsed or refractory large B-cell lymphoma points to the benefits of bringing advanced therapies closer to patients, minimizing hospitalizations (WASHINGTON – September 30, 2024) In the largest prospective study...
Read moreASH Announces Sickle Cell Disease Research Priorities to Accelerate Treatments and Comprehensive Care
Research priorities will help direct the field and deliver progress for the next five years (WASHINGTON, September 25, 2024) — The ÎÚÑ»´«Ã½ (ASH) has released new comprehensive sickle cell disease (SCD) research prioritie...
Read moreStroke Rates Increasing in Individuals Living with SCD Despite Treatment Guidelines
Rising stroke rates indicate need for greater adherence to standard of care and attention to modifiable risk factors (WASHINGTON, September 20, 2024) –The incidence of stroke continues to increase for adults and children living with sickle cell...
Read moreStudy Finds Unique Pattern of Blood Clots in Sickle Cell Trait but Low Overall Clot Risk
23andMe research cohort analysis finds higher risk of venous thromboembolism and pulmonary embolism for people with sickle cell trait, yet relatively low risk of blood clotting overall (WASHINGTON – September 12, 2024) The risk of venous thro...
Read moreASH Recognizes 2024 Quality Improvement Champions
ASH Quality Improvement Champions are standardizing treatment, implementing clinical guidelines to improve patient safety (WASHINGTON, August 27, 2024) – The ÎÚÑ»´«Ã½ (ASH) recognizes Josie Fernandez Sanchez, MD, of Texas Chil...
Read more- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10